Literature DB >> 22470171

Initiating insulin in patients with type 2 diabetes.

Adrian N C Lau1, Terence Tang, Henry Halapy, Kevin Thorpe, Catherine H Y Yu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22470171      PMCID： PMC3328521          DOI： 10.1503/cmaj.110779

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  96 in total

1.  A randomized controlled trial examining combinations of repaglinide, metformin and NPH insulin.

Authors:  M J Davies; P K Thaware; J R Tringham; J Howe; J Jarvis; V Johnston; D L Kitchener; T C Skinner; P G McNally; I G Lawrence
Journal:  Diabet Med       Date:  2007-04-02       Impact factor: 4.359

2.  Safety and efficacy of repaglinide in combination with metformin and bedtime NPH insulin as an insulin treatment regimen in type 2 diabetes.

Authors:  Miguel Civera; Angel Merchante; María Salvador; Javier Sanz; Isidoro Martínez
Journal:  Diabetes Res Clin Pract       Date:  2007-08-21       Impact factor: 5.602

3.  Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.

Authors:  Olga Ushakova; Vera Sokolovskaya; Alla Morozova; Farida Valeeva; Olga Zanozina; Olga Sazonova; Elena Zhadanova; Maria Starceva; Elena Kazakova; Marina Saifullina; Irina Shapiro; Alexander Tarasov; Bassam Al-Tayar; Ninella Starkova
Journal:  Clin Ther       Date:  2007-11       Impact factor: 3.393

4.  Treatment satisfaction and quality of life using an early insulinization strategy with insulin glargine compared to an adjusted oral therapy in the management of Type 2 diabetes: the Canadian INSIGHT Study.

Authors:  Robyn Houlden; Stuart Ross; Stewart Harris; Jean-Francois Yale; Luc Sauriol; Hertzel C Gerstein
Journal:  Diabetes Res Clin Pract       Date:  2007-05-09       Impact factor: 5.602

5.  Acarbose and metabolic control in patients with type 2 diabetes with newly initiated insulin therapy.

Authors:  O Schnell; G Mertes; E Standl
Journal:  Diabetes Obes Metab       Date:  2007-11       Impact factor: 6.577

6.  Improving glycemic control with insulin detemir using the 303 Algorithm in insulin naïve patients with type 2 diabetes: a subgroup analysis of the US PREDICTIVE 303 study.

Authors:  Jean-Louis Selam; Christoph Koenen; Wayne Weng; Luigi Meneghini
Journal:  Curr Med Res Opin       Date:  2008-01       Impact factor: 2.580

7.  Weight gain in type 2 diabetes mellitus--not all uphill.

Authors:  Ohad Cohen; Clara Norymberg; Eylon Neumann; Hilla Dekel
Journal:  Diabetes Res Clin Pract       Date:  2007-08-27       Impact factor: 5.602

8.  Transition to insulin in Type 2 diabetes: family physicians' misconception of patients' fears contributes to existing barriers.

Authors:  Sasson Nakar; Gila Yitzhaki; Reena Rosenberg; Shlomo Vinker
Journal:  J Diabetes Complications       Date:  2007 Jul-Aug       Impact factor: 2.852

9.  Initiation of insulin glargine in suboptimally controlled patients with type 2 diabetes: sub-analysis of the AT.LANTUS trial comparing treatment outcomes in subjects from primary and secondary care in the UK.

Authors:  M Davies; R Evans; F Storms; R Gomis; K Khunti
Journal:  Diabetes Obes Metab       Date:  2007-09       Impact factor: 6.577

10.  Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention).

Authors:  Hertzel Gerstein; Salim Yusuf; Matthew C Riddle; Lars Ryden; Jackie Bosch
Journal:  Am Heart J       Date:  2007-11-26       Impact factor: 4.749
View more
  10 in total

1.  Breaking down barriers to initiating insulin: Insulin prescription pad.

Authors:  Alia Ali; Alice Y Y Cheng; Catherine H Yu
Journal:  Can Fam Physician       Date:  2015-05       Impact factor: 3.275

2.  Development and Psychometric Evaluation of the Hypoglycemia Perspectives Questionnaire in Patients with Type 2 Diabetes Mellitus.

Authors:  Ariane K Kawata; Hilary Wilson; Siew Hwa Ong; Karoly Kulich; Karin Coyne
Journal:  Patient       Date:  2016-10       Impact factor: 3.883

3.  High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study.

Authors:  Matthew D Campbell; Drazen Babic; Uros Bolcina; Lea Smirčić-Duvnjak; Tsvetalina Tankova; Asimina Mitrakou; Peter Kempler; Andrej Janez
Journal:  Acta Diabetol       Date:  2019-04-16       Impact factor: 4.280

Review 4.  Concepts and clinical use of ultra-long basal insulin.

Authors:  Freddy Goldberg Eliaschewitz; Tânia Barreto
Journal:  Diabetol Metab Syndr       Date:  2016-01-06       Impact factor: 3.320

5.  Lipid Fingerprinting in Mild versus Severe Forms of Gestational Diabetes Mellitus.

Authors:  Bárbara Yasmin Gueuvoghlanian-Silva; Fernanda Bertuccez Cordeiro; Thalita Frutuoso Lobo; Thaís Regiani Cataldi; Edson Guimarães Lo Turco; Ricardo Pimenta Bertolla; Rosiane Mattar; Maria Regina Torloni; Silvia Daher
Journal:  PLoS One       Date:  2015-12-03       Impact factor: 3.240

6.  Adherence to Basal Insulin Therapy Among People with Type 2 Diabetes: A Retrospective Cohort Study of Costs and Patient Outcomes.

Authors:  Magaly Perez-Nieves; Kristina S Boye; Jacek Kiljanski; Dachung Cao; Maureen J Lage
Journal:  Diabetes Ther       Date:  2018-04-11       Impact factor: 2.945

Review 7.  Second-Generation Insulin Analogues - a Review of Recent Real-World Data and Forthcoming Head-to-Head Comparisons.

Authors:  Didac Mauricio; Irene Hramiak
Journal:  Eur Endocrinol       Date:  2018-05-11

8.  Intensification to injectable therapy in type 2 diabetes: mixed methods study (protocol).

Authors:  Simon de Lusignan; William Hinton; Emmanouela Konstantara; Neil Munro; Martin Whyte; Julie Mount; Michael Feher
Journal:  BMC Health Serv Res       Date:  2019-05-03       Impact factor: 2.655

9.  Unmet Needs in the Management of Type 2 Diabetes Mellitus Patients Starting Insulin Therapy with Basal or Premix Insulin in Routine Clinical Practice in Serbia.

Authors:  Teodora M Beljić Živković; Boris J Đinđić; Dušica Ž Šuluburić Toljić; Koviljka T Milenković Vulović; Dragana L Udovičić; Dragan Z Zdravković
Journal:  Diabetes Ther       Date:  2018-11-19       Impact factor: 2.945

10.  Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes: Prescription According to Reimbursement Constraints and Guideline Recommendations in Catalonia.

Authors:  Josep Franch-Nadal; Manel Mata-Cases; Emilio Ortega; Jordi Real; Mònica Gratacòs; Bogdan Vlacho; Joan Antoni Vallés; Dídac Mauricio
Journal:  J Clin Med       Date:  2019-09-05       Impact factor: 4.241
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.